Yicheng Mao, Ph.D.
Affiliations: | 2012 | Pharmacy | Ohio State University, Columbus, Columbus, OH |
Area:
PharmacyGoogle:
"Yicheng Mao"Parents
Sign in to add mentor| Natarajan Muthusamy | grad student | 2012 | Ohio State | |
| (Monoclonal Antibody and Liposomal Nanoparticle-based Targeting Therapies for Chronic Lymphocytic Leukemia.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mani R, Mao Y, Frissora FW, et al. (2015) Tumor antigen ROR1 targeted drug delivery mediated selective leukemic but not normal B-cell cytotoxicity in chronic lymphocytic leukemia. Leukemia. 29: 346-55 |
| Mao Y, Wang J, Zhao Y, et al. (2014) Quantification of OSU-2S, a novel derivative of FTY720, in mouse plasma by liquid chromatography-tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 98: 160-5 |
| Mao Y, Wang J, Zhao Y, et al. (2014) A novel liposomal formulation of FTY720 (fingolimod) for promising enhanced targeted delivery. Nanomedicine : Nanotechnology, Biology, and Medicine. 10: 393-400 |
| Wu Y, Kwak KJ, Agarwal K, et al. (2013) Detection of extracellular RNAs in cancer and viral infection via tethered cationic lipoplex nanoparticles containing molecular beacons. Analytical Chemistry. 85: 11265-74 |
| Yu B, Mao Y, Yuan Y, et al. (2013) Targeted drug delivery and cross-linking induced apoptosis with anti-CD37 based dual-ligand immunoliposomes in B chronic lymphocytic leukemia cells. Biomaterials. 34: 6185-93 |
| Wu Y, Crawford M, Mao Y, et al. (2013) Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer. Molecular Therapy. Nucleic Acids. 2: e84 |
| Mao Y, Triantafillou G, Hertlein E, et al. (2013) Milatuzumab-conjugated liposomes as targeted dexamethasone carriers for therapeutic delivery in CD74+ B-cell malignancies. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 347-56 |
| Yu B, Mao Y, Bai LY, et al. (2013) Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia. Blood. 121: 136-47 |
| Mani R, Mao Y, Frissora FW, et al. (2013) Tumor Antigen ROR1 Targeted Delivery Of FTY720 Derivative OSU-2S Prolongs Survival In ROR1 Engineered Mouse Model Of Chronic Lymphocytic Leukemia Blood. 122: 4168-4168 |
| Yu B, Hsu SH, Zhou C, et al. (2012) Lipid nanoparticles for hepatic delivery of small interfering RNA. Biomaterials. 33: 5924-34 |